A team of researchers at the Korean Advanced Institute of Science (KAIST) has successfully developed a brain-machine interface (BMI) that decodes human brain signals to control robot arms without the need for long-term training.BMI is drawing attention as an auxiliary technology that allows patients
Lunit said it signed a collaboration agreement with the Abu Dhabi Health Services Company (SEHA) to test its artificial intelligence (AI)-based radiology software in the Middle East. Under the accord, Lunit and SEHA will proceed with a proof of concept (POC) of the Lunit INSIGHT CXR, an AI solution
Noul, a Korean medical diagnostics company, said on Monday that it signed a memorandum of understanding (MOU) with Institut Pasteur Cameroon to strengthen malaria diagnosis and joint research in the central African country.Accordingly, the two organizations will collaborate to improve its malaria di
In August, drones came to the forefront as convenience stores in Korea started pilot testing drone delivery to remote areas. However, this is just the beginning, as the Ministry of Land Infrastructure and Transport (MOLIT) is conducting demonstration projects to expand the use of drones in Korea.In
Ybrain, a company specializing in mental health diagnostics and therapeutics, said on Wednesday prescriptions for MINDD STIM, a prescription depression electroceutical for at-home use, exceeded 6,000.MINDD STIMM is a wireless headband wearable device that delivers non-invasive brain stimulation thro
Wells Bio, a subsidiary of Access Bio, said it has obtained local approval for "careUS COVID/Flu A&B Antigen Duo," a diagnostic kit that simultaneously detects the Covid-19 virus and influenza A/B viruses.The kit tests SARS-CoV-2 antigen and influenza virus type A and B antigens through an immunochr
The upcoming CES 2023, to be held from Jan.5-8 next year in Las Vegas, Nev., in the U.S., will offer a 40 percent larger venue, becoming the largest in-person meet in the U.S. since 2020, the event organizer Consumer Technology Association said. Hundreds of tech industry leaders will gather at the J
ATsens, a bio-signal-based healthcare platform company, said on Tuesday that its patch-type long-term continuous electrocardiogram (AT-Patch, ATP-C130) obtained U.S. FDA approval on Oct. 10.AT-Patch is the first domestic long-term continuous wearable electrocardiogram (ECG) device to be licensed in
VUNO said on Tuesday that its artificial intelligence (AI)-based bone age reading assistance solution, VUNO Med-BoneAge, has obtained medical device certification from the Taiwanese Food and Drug Administration (TFDA).Vuno had already signed a local distribution contract with CHC Healthcare Group, T
Lunit said its artificial intelligence (AI)-based imaging analysis solution Lunit Insight CXR's reading accuracy was similar to that of a radiologist with more than 20 years of experience in a recent study. Lunit conducted the study jointly with the University of Edinburgh's Queen's Medical Research
Lunit, a company specializing in medical artificial intelligence (AI) solutions, said on Thursday that the number of domestic and foreign medical institutions using its AI imaging solutions for mammography and chest X-ray has surpassed 1,000.Lunit Insight CXR diagnoses 10 chest diseases such as lung
Neofect, a company specializing in digital rehabilitation, is facing financial troubles as it failed to pay back the principal plus interest.According to the company, it has failed to pay back the principal and interest worth 3.3 billion won ($2.3 million), which is equivalent to 21.5 percent of the
VUNO said it has obtained the Ministry of Food and Drug Safety (MFDS) certification for Hativ P30, an artificial intelligence (AI)-based electrocardiogram (ECG) device for at-home use. The device analyzes ECG data to check normal sinus rhythm, atrial fibrillation, bradycardia, and tachycardia.The sm
Neurophet said Thursday that the company signed a contract to provide brain disease image analysis service for the Korea National Institute of Health (NIH) to establish research data for reading and studying brain disease image data.“The project to build research data through reading brain disease i
In-vitro diagnostic medical device companies, whose stock prices soared amid expectations for growth during the COVID-19 pandemic, are struggling to escape from a recent slump.Top diagnostic companies, including Seegene, SD Biosensor, and Humasis, have also seen their share prices drop sharply.Seege
Plasmapp, a bio plasma technology company, said it would expand its research and development (R&D) platform to accelerate the development of its pipeline biomedical devices by going public on the Kosdaq market this month.The company was founded at the lab of the Korea Advanced Institute of Science a
Korea is utilizing only a fraction of the potential of next generation sequencing (NGS) and has yet to recognize the full value of the platform, Illumina's sales head for the Asia region said."Korea should make efforts to let the public know the cost-effectiveness of NGS in reducing medical costs,"
Panagene, a domestic molecular diagnostics company, said on Tuesday that it obtainedapproval from the Ministry of Food and Drug Administration (MFDS) for its PNA Clamp TERT Mutation Detection Kit.The telomerase reverse transcriptase (TERT) gene is a key factor in elongating telomeres, a repeatable s
“Patient-centeredness" is essential to develop digital healthcare, an expert pointed out Thursday. Moving away from the existing evaluation of commercial viability, it is necessary to look at it differently with an assessment focusing on the value that can be given to patients, the expert added.Lee
NGeneBio said on Friday it has developed a prototype of a blood-based in vitro diagnostic device to detect early dementia using a biomarker discovered in the National Dementia Research and Development project.The importance of early diagnosis of dementia is growing in Korea with the rapid population